Predict your next investment

Venture Capital
photonfund.cn

See what CB Insights has to offer

Investments

12

Portfolio Exits

1

About Photon Fund

Photon Fund is a venture capital institution that focuses on A or B round investments in TMT and high-end manufacturing fields.

Photon Fund Headquarter Location

Shenzhen, Guangdong,

China

+86) 755 23884646

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Photon Fund News

Amplicore: Closes $4M Seed Funding

Mar 28, 2021

Amplicore Inc., a Cincinnati, OH-based early-stage biopharmaceutical company, closed its $4m seed round of funding The round was led by Photon Fund, with participation from Industrial Technology Investment Corporation, Berkeley Catalyst Fund, and SVE Capital Amplicore is a biopharmaceutical company currently developing locally delivered and minimally invasive therapeutic solutions for musculoskeletal diseases The company intends to use the funds to complete the preclinical development of its two leading products, AM3101 and AM1101, and position itself for the next round of financing Amplicore is also leveraging a study on the healing of acute meniscal tear after surgical repair, supported by a grant from the US Department of Defense (DoD) The company is also developing AM1101 as a treatment for osteoarthritis (OA) designed to reduce joint OA pain, inhibit cartilage degradation Tags:

Photon Fund Investments

12 Investments

Photon Fund has made 12 investments. Their latest investment was in ABMTX as part of their Series B on January 1, 2022.

CBI Logo

Photon Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/4/2022

Series B

ABMTX

$30M

Yes

3

11/6/2020

Series A

Zhimeng Biopharma

$34.76M

Yes

4

10/28/2020

Series B

Newomics

$7.9M

Yes

Berkeley Catalyst Fund, LDV Partners, MSA Capital, and Undisclosed Investors

3

9/17/2020

Series A - III

Subscribe to see more

$99M

Subscribe to see more

10

4/16/2020

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/4/2022

11/6/2020

10/28/2020

9/17/2020

4/16/2020

Round

Series B

Series A

Series B

Series A - III

Series A - II

Company

ABMTX

Zhimeng Biopharma

Newomics

Subscribe to see more

Subscribe to see more

Amount

$30M

$34.76M

$7.9M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Berkeley Catalyst Fund, LDV Partners, MSA Capital, and Undisclosed Investors

Sources

3

4

3

10

10

Photon Fund Portfolio Exits

1 Portfolio Exit

Photon Fund has 1 portfolio exit. Their latest portfolio exit was FutureMove Automotive on October 08, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/8/2019

Acquired

$99M

4

Date

10/8/2019

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

4

Photon Fund Team

2 Team Members

Photon Fund has 2 team members, including current Founding Partner, David Wang.

Name

Work History

Title

Status

David Wang

Founding Partner

Current

Qing Zhu

Founding Partner

Current

Name

David Wang

Qing Zhu

Work History

Title

Founding Partner

Founding Partner

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.